OPKO Health (OPK) Misses Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.72 +3.61%
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
LTBR, AES, SYRS, More
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
OPKO Health (NYSE: OPK) reported Q3 EPS of ($0.11), $0.04 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $19.8 million versus the consensus estimate of $25.2 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Parametric Sound (PAMT) Misses Q3 EPS by 31c
- EverQuote (EVER) Tops Q3 EPS by 2c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
